Analysts’ Updated EPS Estimates for December, 6th (AMG, BLK, CHD, CLDR, CLX, CRMD, DCI, DIC, ENR, EW)

Share on StockTwits

Analysts’ updated eps estimates for Thursday, December 6th:

Affiliated Managers Group (NYSE:AMG) had its buy rating reissued by analysts at Bank of America Corp. They currently have a $130.00 price target on the stock, down from their previous price target of $155.00.

BlackRock (NYSE:BLK) had its buy rating reissued by analysts at Bank of America Corp. They currently have a $478.00 price target on the stock, down from their previous price target of $525.00.

Church & Dwight (NYSE:CHD) had its underperform rating reissued by analysts at Bank of America Corp. The firm currently has a $66.00 target price on the stock, up from their previous target price of $58.00.

Cloudera (NYSE:CLDR) had its neutral rating reaffirmed by analysts at Bank of America Corp. They currently have a $18.00 target price on the stock, down from their previous target price of $22.00.

Clorox (NYSE:CLX) had its neutral rating reiterated by analysts at Bank of America Corp. Bank of America Corp currently has a $170.00 target price on the stock, up from their previous target price of $150.00.

Roth Capital began coverage on shares of CorMedix (NYSEAMERICAN:CRMD). Roth Capital issued a buy rating and a $6.00 price target on the stock.

Donaldson (NYSE:DCI) had its hold rating reissued by analysts at Stifel Nicolaus. The firm currently has a $53.00 price target on the stock.

DIC Asset (ETR:DIC) had its buy rating reaffirmed by analysts at DZ Bank AG.

Energizer (NYSE:ENR) had its underperform rating reaffirmed by analysts at Bank of America Corp. The firm currently has a $45.00 target price on the stock, down from their previous target price of $50.00.

Edwards Lifesciences (NYSE:EW) had its positive rating reiterated by analysts at Stifel Nicolaus.

GlaxoSmithKline (NYSE:GSK) had its equal weight rating reissued by analysts at Barclays PLC.

HealthStream (NASDAQ:HSTM) had its hold rating reissued by analysts at Barrington Research.

Intercept Pharmaceuticals (NASDAQ:ICPT) had its buy rating reiterated by analysts at Cantor Fitzgerald. They currently have a $170.00 price target on the stock. The analysts wrote, “: We reiterate our Overweight rating and $170 12-month price target. We think Elafibranor Ph2 PBC data from Genfit (GNFT.PA, Not covered) looks competitive among Ph2 assets but we do not view today’s update as a near or mid-term threat to ICPT’s OCA. Elafibranor Ph2 looks broadly similar to recently updated Sedalapar data (for 52-week analysis) from Cymabay (CBAY, OW E. Merle) which is not surprising as both are PPAR agonists, but detailed full data could be helpful in comparing the efficacy and safety profiles of these assets. We think pivotal PBC trial enrollment will take time before either asset would pose a commercial threat to OCA in PBC. We remain focused on REGENERATE readout in NASH for ICPT in 1H 2019.””

Mplx (NYSE:MPLX) had its neutral rating reiterated by analysts at Bank of America Corp. The firm currently has a $41.00 price target on the stock, up from their previous price target of $36.00.

National Bank of Canada (OTCMKTS:NTIOF) had its hold rating reaffirmed by analysts at Barclays PLC.

National Bank of Canada (OTCMKTS:NTIOF) had its hold rating reiterated by analysts at Canaccord Genuity.

Nu Skin Enterprises (NYSE:NUS) had its underperform rating reaffirmed by analysts at Bank of America Corp. Bank of America Corp currently has a $65.00 target price on the stock, down from their previous target price of $75.00.

Okta (NASDAQ:OKTA) had its hold rating reiterated by analysts at Robert W. Baird. The firm currently has a $65.00 price target on the stock. The analysts wrote, “We maintain our Neutral rating and $65 price target on Okta after reporting very strong FQ3 results. We believe a first mover advantage, strong competitive positioning, and a growing awareness of the importance of identity in driving agility and security for cloud is and will continue to support a robust growth opportunity for Okta. However, trading at the high-end of secular SaaS peers, we believe the opportunity is captured in current valuation.””

Planet Fitness (NYSE:PLNT) had its neutral rating reaffirmed by analysts at Bank of America Corp. Bank of America Corp currently has a $68.00 price target on the stock, up from their previous price target of $62.00.

Nomura started coverage on shares of Protagonist Therapeutics (NASDAQ:PTGX). Nomura issued a buy rating and a $13.00 price target on the stock.

T. Rowe Price Group (NASDAQ:TROW) had its buy rating reissued by analysts at Bank of America Corp. The firm currently has a $108.00 target price on the stock, down from their previous target price of $125.00.

Viewray (NASDAQ:VRAY) had its buy rating reissued by analysts at Northland Securities. Northland Securities currently has a $20.00 price target on the stock. The analysts wrote, “We now expect Elekta to begin a full commercial launch beginning Q1-19 (calendar).””

Virtus Investment Partners (NASDAQ:VRTS) had its neutral rating reaffirmed by analysts at Bank of America Corp. They currently have a $100.00 target price on the stock, down from their previous target price of $115.00.

Western Digital (NASDAQ:WDC) had its buy rating reaffirmed by analysts at Bank of America Corp. The firm currently has a $68.00 target price on the stock, down from their previous target price of $75.00.

Receive News & Ratings for Affiliated Managers Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affiliated Managers Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Energi  Price Hits $1.21 on Exchanges
Energi Price Hits $1.21 on Exchanges
NuBits Hits Market Capitalization of $437,069.00
NuBits Hits Market Capitalization of $437,069.00
Eaton Vance  Sets New 52-Week Low at $34.55
Eaton Vance Sets New 52-Week Low at $34.55
FCB Financial  Reaches New 12-Month Low at $33.27
FCB Financial Reaches New 12-Month Low at $33.27
Lightpaycoin  24 Hour Volume Hits $83,656.00
Lightpaycoin 24 Hour Volume Hits $83,656.00
Bridge Protocol 1-Day Trading Volume Tops $79.00
Bridge Protocol 1-Day Trading Volume Tops $79.00


Leave a Reply

 
© 2006-2018 Zolmax.